▸ 15 Sep 2026, 16:40 Change in substantial holding from RYD Substantial Holders
▸ 15 Sep 2026, 12:38 Section 708A Cleansing Statement Securities Administration
▸ 15 Sep 2026, 12:37 Application for quotation of securities - LDX Securities Administration
▸ 15 Sep 2026, 09:26 FebriDx Commercial Traction Continues Across US Accounts Company Update
▸ 1 Sep 2026, 13:50 Section 708A Cleansing Statement Securities Administration
▸ 1 Sep 2026, 13:48 Application for quotation of securities - LDX Securities Administration
▸ 1 Sep 2026, 13:04 Change of Director's Interest Notice - DW Director Interests
▸ 26 Aug 2026, 10:06 Appendix 4G and Corporate Governance Statement Company Administration
▸ 26 Aug 2026, 09:44 FY26 Full Year Results Announcement Financial Results
▸ 26 Aug 2026, 09:41 FY26 Annual Report Financial Results
▸ 26 Aug 2026, 09:22 FY26 Appendix 4E Financial Results
▸ 7 Aug 2026, 11:02 Lumos to Present at 20th Bioshares Biotech Summit Presentations
▸ 4 Aug 2026, 09:04 Lumos Receives FebriDx Order from PHASE Scientific Company Update
▸ 30 Jul 2026, 09:38 Lumos Secures Distribution for FebriDx in Romania Company Update
▸ 28 Jul 2026, 12:42 Change of Director's Interest Notice - DW Director Interests
▸ 28 Jul 2026, 09:40 Section 708A Cleansing Statement Securities Administration
▸ 28 Jul 2026, 09:37 Application for quotation of securities - LDX Securities Administration
▸ 27 Jul 2026, 12:01 Investor Presentation Presentations
▸ 27 Jul 2026, 09:55 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 21 Jul 2026, 12:08 FebriDx Commercial Traction Across Priority US Accounts Company Update
▸ 20 Jul 2026, 11:01 Q4 FY26 Results Release Date and Webinar Invitation Periodic Reports
▸ 20 Jul 2026, 10:50 Investor Information Sessions Company Administration
▸ 14 Jul 2026, 13:06 Notification of cessation of securities - LDX Securities Administration
▸ 2 Jul 2026, 14:27 Closure of A$5M Loan Facility with Major Shareholders Capital Raising
▸ 29 Jun 2026, 09:54 Lumos Receives Research & Development Tax Rebate Periodic Reports
▸ 25 Jun 2026, 11:48 Change of Director's Interest Notice - SL Director Interests
▸ 22 Jun 2026, 12:12 Application for quotation of securities - LDX Securities Administration
▸ 19 Jun 2026, 09:13 Change of Director's Interest Notice - CR Director Interests
▸ 11 Jun 2026, 09:58 Investor Presentation - FebriDx US Commercial Update Presentations
▸ 5 Jun 2026, 14:51 Change of Director's Interest Notice - DW Director Interests
▸ 4 Jun 2026, 11:23 FebriDx US Commercial Update Webinar Invitation Presentations
▸ 20 May 2026, 13:24 Application for quotation of securities - LDX Securities Administration
▸ 20 May 2026, 13:24 Section 708A Cleansing Statement Securities Administration
▸ 18 May 2026, 11:42 FebriDx U.S. Rollout and Reimbursement Update - Amended Company Update
▸ 18 May 2026, 09:49 FebriDx U.S. Rollout and Reimbursement Update Company Update
▸ 14 May 2026, 09:37 FebriDx Paediatric Study Enrolment Milestone Achieved Company Update
▸ 7 May 2026, 14:02 Lumos receives US$0.5m CLIA waiver milestone payment Periodic Reports
▸ 1 May 2026, 11:16 Change of Director's Interest Notice - CR Director Interests
▸ 1 May 2026, 11:16 Change of Director's Interest Notice - SL Director Interests
▸ 1 May 2026, 11:11 Notification regarding unquoted securities - LDX Securities Administration
▸ 1 May 2026, 11:10 Notification regarding unquoted securities - LDX Securities Administration
▸ 1 May 2026, 11:08 Application for quotation of securities - LDX Securities Administration
▸ 1 May 2026, 11:04 Results of Share Purchase Plan Capital Raising
▸ 30 Apr 2026, 16:23 Change of Director's Interest Notice - SL Director Interests
▸ 21 Apr 2026, 10:32 Q3 FY26 Results Investor Presentation Quarterly Reports
▸ 20 Apr 2026, 09:49 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 16 Apr 2026, 09:33 Notification of cessation of securities - LDX Securities Administration
▸ 15 Apr 2026, 16:26 Lumos Q3 FY26 Results Webinar Invitation Capital Raising
▸ 14 Apr 2026, 14:35 Lumos expands WellStreet Urgent Care locations Company Update
▸ 14 Apr 2026, 10:14 Change in substantial holding from RYD Substantial Holders
▸ 14 Apr 2026, 09:13 Lumos receives US$5m FebriDx milestone payment from PHASE Company Update
▸ 10 Apr 2026, 17:31 Response to ASX Aware Letter ASX Query
▸ 10 Apr 2026, 09:32 Target Market Determination Other
▸ 10 Apr 2026, 09:31 Prospectus Securities Administration
▸ 10 Apr 2026, 09:30 SPP - Letter to Eligible Shareholders Capital Raising
▸ 9 Apr 2026, 12:10 Application for quotation of securities - LDX Securities Administration
▸ 9 Apr 2026, 12:10 Section 708A Cleansing Statement Securities Administration
▸ 9 Apr 2026, 12:06 Application for quotation of securities - LDX Securities Administration
▸ 9 Apr 2026, 12:05 Section 708A Cleansing Statement Securities Administration
▸ 8 Apr 2026, 09:45 Lumos secures new contract manufacturing agreement Company Update
▸ 2 Apr 2026, 12:01 Section 708A Cleansing Statement Securities Administration
▸ 2 Apr 2026, 12:00 Application for quotation of securities - LDX Securities Administration
▸ 1 Apr 2026, 10:47 Lumos receives largest FebriDx order to date Company Update
▸ 27 Mar 2026, 16:33 Investor Briefing Invitation Presentations
▸ 27 Mar 2026, 10:13 Investor Presentation Capital Raising
▸ 27 Mar 2026, 10:08 Proposed issue of securities - LDX Securities Administration
▸ 27 Mar 2026, 10:08 Proposed issue of securities - LDX Securities Administration
▸ 27 Mar 2026, 10:08 Lumos completes $20m placement and launches SPP Capital Raising
▸ 27 Mar 2026, 10:08 US FDA Grants CLIA Waiver for FebriDx Company Update
▸ 25 Mar 2026, 09:21 Trading Halt Trading Halt / Suspension
▸ 5 Mar 2026, 09:34 Section 708A Cleansing Statement Securities Administration
▸ 5 Mar 2026, 09:32 Application for quotation of securities - LDX Securities Administration
▸ 3 Mar 2026, 10:31 1H FY26 Results Investor Presentation Financial Results
▸ 27 Feb 2026, 09:49 Lumos Delivers Several Pivotal Milestones in 1H FY26 Financial Results
▸ 27 Feb 2026, 09:47 Appendix 4D and Half Year Report Financial Results
▸ 23 Feb 2026, 09:45 Lumos Completes Enrolment Milestone for Paediatric Study Company Update
▸ 6 Feb 2026, 09:06 Section 708A Cleansing Statement Securities Administration
▸ 6 Feb 2026, 09:03 Application for quotation of securities - LDX Securities Administration
▸ 3 Feb 2026, 09:27 Q2 FY26 Results Investor Presentation Presentations
▸ 29 Jan 2026, 14:22 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 19 Jan 2026, 10:48 Lumos secures follow on contract with Aptatek Company Update
▸ 9 Jan 2026, 17:01 Section 708A Cleansing Statement Securities Administration
▸ 9 Jan 2026, 16:58 Application for quotation of securities - LDX Securities Administration
▸ 7 Jan 2026, 12:20 Investor Webinar Invitation-Reducing Diagnostic Uncertainty Presentations
▸ 18 Dec 2025, 12:07 Lumos Secures Distribution for FebriDx in Baltic Region Company Update
▸ 21 Nov 2025, 13:22 Section 708A Cleansing Statement Securities Administration
▸ 21 Nov 2025, 13:20 Application for quotation of securities - LDX Securities Administration
▸ 21 Nov 2025, 13:17 Lumos Secures 100% US Medicare Reimbursement for FebriDx Company Update
▸ 20 Nov 2025, 08:30 Lumos Enters Strategic Collaboration with AcuityMD Company Update
▸ 12 Nov 2025, 15:29 Notification regarding unquoted securities - LDX Securities Administration
▸ 31 Oct 2025, 16:34 Application for quotation of securities - LDX Securities Administration
▸ 31 Oct 2025, 16:31 Change of Director's Interest Notice - DW Director Interests
▸ 31 Oct 2025, 16:26 Notification regarding unquoted securities - LDX Securities Administration
▸ 28 Oct 2025, 16:32 New Constitution Securities Administration
▸ 24 Oct 2025, 12:49 Results of Annual General Meeting Meetings & Governance
▸ 24 Oct 2025, 08:56 2025 AGM Presentation Presentations
▸ 24 Oct 2025, 08:51 AGM Chair Address Letters & Addresses
▸ 23 Oct 2025, 08:34 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 22 Oct 2025, 09:35 Lumos Commences FebriDx CLIA Waiver Pediatric Study Company Update
▸ 16 Oct 2025, 09:34 Lumos Agreement with WellStreet Urgent Care for FebriDx Company Update